Head to Head Contrast: INVO Bioscience (NASDAQ:INVO) vs. Autonomix Medical (NASDAQ:AMIX)

INVO Bioscience (NASDAQ:INVO) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Analyst Ratings

This is a summary of current ratings for INVO Bioscience and Autonomix Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Bioscience	0	0	0	0	0.00
Autonomix Medical	0	0	1	0	3.00

Autonomix Medical has a consensus target price of $28.00, indicating a potential upside of 1,279.31%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than INVO Bioscience.

Risk & Volatility

INVO Bioscience has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -5.4, suggesting that its stock price is 640% less volatile than the S&P 500.

Institutional and Insider Ownership

12.0% of INVO Bioscience shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 3.5% of INVO Bioscience shares are held by company insiders. Comparatively, 32.4% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares INVO Bioscience and Autonomix Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Bioscience	$5.77 million	1.81	-$8.03 million	N/A	N/A
Autonomix Medical	N/A	N/A	-$15.43 million	($12.93)	-0.16

INVO Bioscience has higher revenue and earnings than Autonomix Medical.

Profitability

This table compares INVO Bioscience and Autonomix Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Bioscience	-122.79%	N/A	-36.94%
Autonomix Medical	N/A	-212.48%	-161.13%

Summary

INVO Bioscience beats Autonomix Medical on 6 of the 11 factors compared between the two stocks.

About INVO Bioscience

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.